Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07129980 · ClinicalTrials.gov registry record
Refractive and Visual Outcomes With the ARGOS Biometer In Eyes With a History of Refractive Surgery: ARGOS Study
A clinical trial of Cataract, sponsored by Vance Thompson Vision.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07129980 is a study of Cataract that has completed, run by Vance Thompson Vision. The registered enrollment target is 20 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07129980, a study of Cataract, has completed, sponsored by Vance Thompson Vision.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is to evaluate the visual and refractive outcomes in eyes with prior myopic refractive surgery undergoing cataract surgery for intraocular lens (IOL) power calculations.
Conditions Studied
Interventions
- DEVICE ARGOS Biometer
Study Locations (1)
South Dakota
- Vance Thompson Vision Clinic, Prof. LLC - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2025-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07129980
The ClinicalTrials.gov registry entry for NCT07129980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (91% lower). The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which ARGOS Biometer is the first listed.
NCT07129980 reports 1 study location spanning 1 distinct geographic area - top geographies include South Dakota.
Frequently Asked Questions
What is clinical trial NCT07129980 about?
NCT07129980 is a clinical study titled "Refractive and Visual Outcomes With the ARGOS Biometer In Eyes With a History of Refractive Surgery: ARGOS Study". The study is to evaluate the visual and refractive outcomes in eyes with prior myopic refractive surgery undergoing cataract surgery for intraocular lens (IOL) power calculations.
What is the current status of trial NCT07129980?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2023-07-11. Estimated completion is 2025-08-01.
What conditions does trial NCT07129980 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT07129980?
The interventions under investigation include: ARGOS Biometer (DEVICE).
Who is sponsoring clinical trial NCT07129980?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07129980 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.